❌

Normal view

Received — 1 September 2025 ⏭ Epigenetics

Most Recent Articles: Clinical Epigenetics
Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMTmethylated/DGKImethylated glioblastoma Jean-Maxime Besson · Amandine Etcheverry · Arulraj Nadaradjane · Gwenola Bougras-Cartron · Marc Aubry · Jean-Sebastien Frenel · Alain Chevanieu · Marie Lopez · Jean Mosser and Pierre-François Cartron
DNA methyltransferase (DNMT) inhibitors are emerging as a promising class of agents for personalized and targeted cancer therapy, particularly in malignancies with limited therapeutic options such as glioblast...
30 August 2025 at 08:00

Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMTmethylated/DGKImethylated glioblastoma

Most Recent Articles: Clinical Epigenetics

By: Jean-Maxime Besson · Amandine Etcheverry · Arulraj Nadaradjane · Gwenola Bougras-Cartron · Marc Aubry · Jean-Sebastien Frenel · Alain Chevanieu · Marie Lopez · Jean Mosser and Pierre-François Cartron

30 August 2025 at 08:00

DNA methyltransferase (DNMT) inhibitors are emerging as a promising class of agents for personalized and targeted cancer therapy, particularly in malignancies with limited therapeutic options such as glioblast...